Sana Biotechnology Inc (SANA) Stock Price, Quote & News

Company Profile

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines in the United States. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including type 1 diabetes, B cell mediated autoimmune diseases, and oncology. The company's product pipeline includes UP421, a HIP-modified allogeneic primary islet cell product, which is in phase 1 clinical trial to treat type 1 diabetes; SC451, a HIP-modifi...

Industry: Biotechnology

Sector: Healthcare

Phone: 206 701 7914

Website: www.sana.com

Address:

188 East Blaine Street, Suite 400, Seattle, United States

JRNY13 Mar. 6 at 7:59 PM

$SANA oof

0 · Reply

Scrapps64 Mar. 6 at 7:19 PM

$SANA Nope, potential cure, afraid you chums are wrong

0 · Reply

JacksonHole Mar. 6 at 5:55 PM

$SANA yep slow bleed to hell

0 · Reply

Sudhakar1990 Mar. 6 at 5:53 PM

$SANA $2.90??

0 · Reply

Scrapps64 Mar. 6 at 5:52 PM

$SANA Bought more today… why not

1 · Reply

JCLuckman Mar. 6 at 5:49 PM

$SANA I'm in with a Starter‼️

0 · Reply

puncho88 Mar. 6 at 4:03 PM

$SANA tis the life of biopharma hang on and avg down

0 · Reply

GLPHOTOX Mar. 6 at 3:53 PM

$SANA This is brutal

0 · Reply

JerryMalone32 Mar. 6 at 3:44 PM

$SANA is acting like a dilutive secondary offering is imminent.

1 · Reply

mirko_papuga Mar. 6 at 3:13 PM

$SANA Ouch. Rough day.. Very rough week.. Down way more than other biotech... Retail investors fleeing? Insitutional investors getting out? Short seller overly agressive on shorting stock??

0 · Reply

Sana Biotechnology, Inc. (SANA) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Mar 3, 2026, 4:05 PM EST - 3 days ago

Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates

Feb 23, 2026, 4:05 PM EST - 11 days ago

Sana Biotechnology to Present at March 2026 Investor Conferences

Feb 13, 2026, 3:24 AM EST - 22 days ago

Sana Biotechnology: A Small, Speculative Play

Jan 19, 2026, 7:40 AM EST - 6 weeks ago

Sana Biotechnology Stock: Promising T1D Science, But Wait For Dips

Jan 14, 2026, 3:26 PM EST - 7 weeks ago

Sana Biotechnology, Inc. (SANA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 7, 2026, 4:26 PM EST - 2 months ago

Sana Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference

Dec 8, 2025, 9:00 AM EST - 3 months ago

Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform

Dec 3, 2025, 5:03 PM EST - 3 months ago

Sana Biotechnology, Inc. (SANA) Presents at Evercore 8th Annual Healthcare Conference Transcript

Dec 2, 2025, 5:43 PM EST - 3 months ago

Sana Biotechnology, Inc. (SANA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Nov 24, 2025, 4:05 PM EST - 3 months ago

Sana Biotechnology to Present at December 2025 Investor Conferences

Oct 16, 2025, 5:09 PM EDT - 5 months ago

Sana Biotechnology: Scope Goes Beyond HIP-Modified Pancreatic Islet Cells For T1D

Oct 16, 2025, 4:18 PM EDT - 5 months ago

Sana Biotechnology: A Big Winner In Waiting? Maybe, But It Won't Happen Overnight

Oct 15, 2025, 12:15 PM EDT - 5 months ago

Sana Biotech Stock — The Next '100-Bagger'?

Sep 8, 2025, 4:34 PM EDT - 6 months ago

Sana Biotechnology, Inc. (SANA) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 5, 2025, 1:42 AM EDT - 6 months ago

Sana Biotechnology, Inc. (SANA) Presents at Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Sep 2, 2025, 10:03 PM EDT - 6 months ago

Sana Biotechnology, Inc. (SANA) Presents At Citi's Biopharma Back To School Conference Transcript

Aug 28, 2025, 8:00 AM EDT - 6 months ago

IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies

FHTX IQV MRNA

Aug 26, 2025, 4:05 PM EDT - 6 months ago

Sana Biotechnology to Present at September 2025 Investor Conferences

Aug 20, 2025, 4:05 PM EDT - 7 months ago

Sana Biotechnology Announces Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares

Aug 8, 2025, 2:58 PM EDT - 7 months ago

Sana Biotechnology: Fundraising Triggers Major Sell-Off, I'm Still Intrigued

Aug 6, 2025, 11:24 PM EDT - 7 months ago

Sana Biotechnology Announces Pricing of Public Offering

Aug 6, 2025, 4:38 PM EDT - 7 months ago

Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Aug 6, 2025, 7:00 AM EDT - 7 months ago

Seres Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Updates

MCRB

Aug 4, 2025, 11:35 AM EDT - 7 months ago

Sana Biotechnology Announces Publication in New England Journal of Medicine of Groundbreaking Clinical Data from Transplantation Without Immunosuppression of Hypoimmune-Modified, Insulin-Producing Islet Cells in Patient with Type 1 Diabetes

Jun 23, 2025, 10:05 AM EDT - 9 months ago

Sana Biotechnology Announces Positive Six-Month Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression

Jun 23, 2025, 7:39 AM EDT - 9 months ago

Two Biotech Stocks Poised For Big Moves On Monday

LCTX

Jun 9, 2025, 4:05 PM EDT - 9 months ago

Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes Association Scientific Sessions

May 28, 2025, 4:05 PM EDT - 10 months ago

Sana Biotechnology to Present at June 2025 Investor Conferences

May 19, 2025, 3:10 PM EDT - 10 months ago

Sana: HIP-Modified Islet Cells To Possibly Change Scope Of Type 1 Diabetes Treatment

May 19, 2025, 11:57 AM EDT - 10 months ago

The End Of The Diabetes Industry? This Small Cap Could Upend The Business Models of Pharma Giants

May 14, 2025, 2:50 PM EDT - 10 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology

May 12, 2025, 4:05 PM EDT - 10 months ago

Sana Biotechnology to Present at the BofA Securities 2025 Healthcare Conference

May 8, 2025, 5:45 AM EDT - 10 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 20, 2025 in Sana Biotechnology, Inc. Lawsuit - SANA

JRNY13 Mar. 6 at 7:59 PM

$SANA oof

0 · Reply

Scrapps64 Mar. 6 at 7:19 PM

$SANA Nope, potential cure, afraid you chums are wrong

0 · Reply

JacksonHole Mar. 6 at 5:55 PM

$SANA yep slow bleed to hell

0 · Reply

Sudhakar1990 Mar. 6 at 5:53 PM

$SANA $2.90??

0 · Reply

Scrapps64 Mar. 6 at 5:52 PM

$SANA Bought more today… why not

1 · Reply

JCLuckman Mar. 6 at 5:49 PM

$SANA I'm in with a Starter‼️

0 · Reply

puncho88 Mar. 6 at 4:03 PM

$SANA tis the life of biopharma hang on and avg down

0 · Reply

GLPHOTOX Mar. 6 at 3:53 PM

$SANA This is brutal

0 · Reply

JerryMalone32 Mar. 6 at 3:44 PM

$SANA is acting like a dilutive secondary offering is imminent.

1 · Reply

mirko_papuga Mar. 6 at 3:13 PM

$SANA Ouch. Rough day.. Very rough week.. Down way more than other biotech... Retail investors fleeing? Insitutional investors getting out? Short seller overly agressive on shorting stock??

0 · Reply

eagles1313 Mar. 6 at 2:43 PM

$SANA 2.6-2.7$ might be support zone.ALso in order to use ATM they need higher prices imo.

0 · Reply

Sudhakar1990 Mar. 6 at 2:33 PM

$SANA why bleeding 🩸

1 · Reply

BBraggHillBoys Mar. 6 at 1:35 PM

$SANA

0 · Reply

puncho88 Mar. 5 at 9:47 PM

$SANA bought a little more to avg down...

0 · Reply

nothingtoChere Mar. 5 at 9:35 PM

$SANA come on SANA

0 · Reply

harrisisme Mar. 5 at 6:38 PM

$SANA great place to buy more I’m in it for the long run

0 · Reply

SKIJK Mar. 5 at 5:45 PM

$SANA WELL the CHINESE never make false statements from Deep Seek, to job numbers, deals or ECONOMY. Just the truth, SURE AM I right?,,, 3 people seems like a lot for a study, 2 would have been plenty, if their mouth is moving, they are LYING!

0 · Reply

mirko_papuga Mar. 5 at 4:39 AM

$SANA Chinese researchers achieved a clinical cure for type 1 diabetes using chemically induced pluripotent stem cells (CiPSCs) to generate functional islet cells, as reported in The Lancet Diabetes & Endocrinology February 26, 2026. https://www.thelancet.com/journals/landia/article/PIIS2213-8587(25)00423-1/fulltext Three people in a study in China received lab-grown insulin-producing cells made from stem cells. All three required immunosuppressive therapy to prevent an immune attack. In one case, researchers created stem cells from the patient’s own cells before turning them into insulin-producing cells. The other two participants received cells made from a stem cell line. Two of the people in the study saw their time in range reach 94% or better, though one person still required insulin (down from 56.5 units per day to 16). A third participant’s first transplant failed and was repeated. Insulin production improved, but the person later discontinued immunosuppressive therapy, and their insulin production stopped.

4 · Reply

BBraggHillBoys Mar. 4 at 2:31 PM

$SANA The scientific and pipeline news is what's going to send this North.

0 · Reply

DARKP00L Mar. 4 at 12:28 PM

$SANA 07:17 on Mar. 04 2026 HC Wainwright & Co. Maintains Buy on Sana Biotechnology, Lowers Price Target to $7 #tradeideas

0 · Reply

JerryMalone32 Mar. 4 at 3:25 AM

$SANA new stock sale agreement between company and Cowen for up to $150 million of stock. Hopefully any offering is when stock price a bit higher.

0 · Reply

BriOnH Mar. 3 at 9:10 PM

$SANA https://ir.sana.com/news-releases/news-release-details/sana-biotechnology-reports-fourth-quarter-and-full-year-2025

0 · Reply

Market Cap	910.02M
Revenue (ttm)	0.00
Net Income (ttm)	-266.76M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	3,828,400
Avg Vol	2,306,560
Day's Range	N/A - N/A
Shares Out	266.87M
Stochastic %K	6%
Beta	1.96
Analysts	Strong Sell
Price Target	$8.43